Perspective · 17 Apr 2024
EditorialPublished 31 Jul 2020
Editorial on Market Analysis for Experimental Stroke and Translational Medicine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market. Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. iData Research has an ever-expanding medical market intelligence library consisting of focused, in-depth, accurate, and exclusive research you will not find anywhere else. Our highly qualified team of industry analysts follow a structured and independent research methodology designed to provide the most valuable return on actionable market data in the world. Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. One trend that has risen as a result of consolidation is the bundling of devices at a discount. Bundling is driven by unfavorable reimbursement conditions and larger competitors who have a wide variety of devices to offer across the interventional cardiology market and are able to negotiate more cost-effective contracts with hospitals and labs. As a result competitive pressure is expected to contribute to declines in prices across the majority of segments in the market.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Experimental Stroke & Translational Medicine.
Perspective · 17 Apr 2024
The Dance of Death: Exploring the Intricacies of Apoptosis in Cellular Fate
Perspective · 17 Apr 2024
Unveiling the Remarkable Potential of Neuroplasticity: How Our Brains Adapt and Evolve
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Experimental Stroke & Translational Medicine
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Stefan Farsky”